Marcus Zervos

23.3k total citations · 4 hit papers
279 papers, 13.1k citations indexed

About

Marcus Zervos is a scholar working on Infectious Diseases, Clinical Biochemistry and Epidemiology. According to data from OpenAlex, Marcus Zervos has authored 279 papers receiving a total of 13.1k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Infectious Diseases, 101 papers in Clinical Biochemistry and 92 papers in Epidemiology. Recurrent topics in Marcus Zervos's work include Antimicrobial Resistance in Staphylococcus (156 papers), Bacterial Identification and Susceptibility Testing (101 papers) and Streptococcal Infections and Treatments (45 papers). Marcus Zervos is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (156 papers), Bacterial Identification and Susceptibility Testing (101 papers) and Streptococcal Infections and Treatments (45 papers). Marcus Zervos collaborates with scholars based in United States, India and Canada. Marcus Zervos's co-authors include Susan Donabedian, Joseph W. Chow, Mary Beth Perri, Dennis R. Schaberg, Jack D. Sobel, Nadia Z. Haque, José A. Vázquez, Ellie Hershberger, Carol A. Kauffman and Jan E. Patterson and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Marcus Zervos

271 papers receiving 12.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emergence of Vancomycin Resistance inStaphylococcus aureus

1999 869 citations Marcus Zervos et al. profile →
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit

2020 456 citations Geehan Suleyman, Kelly Malette et al. profile →
The Mental Health of Transgender Youth: Advances in Understanding

2016 452 citations Marcus Zervos et al. profile →
Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings

2021 176 citations Paul E. Kilgore, Gina Maki et al. International Journal of Infectious Diseases profile →

Peers

Countries citing papers authored by Marcus Zervos

Since Specialization

Citations

This map shows the geographic impact of Marcus Zervos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Zervos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Zervos more than expected).

Fields of papers citing papers by Marcus Zervos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Zervos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Zervos. The network helps show where Marcus Zervos may publish in the future.

Co-authorship network of co-authors of Marcus Zervos

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus Zervos. A scholar is included among the top collaborators of Marcus Zervos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus Zervos. Marcus Zervos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Household Influenza Transmission and Healthcare Resource Utilization Among Patients Treated with Baloxavir vs Oseltamivir: A United States Outpatient Prospective Survey 2024 ·Infectious Diseases and Therapy ·Jennie H. Best, (unknown), Xiaowu Sun, (unknown), (unknown), (unknown), Marcus Zervos	1
2	242. Evaluation of PBP4 promoter variation and clinical outcomes in patients with Enterococcus faecalis bacteremia 2023 ·Open Forum Infectious Diseases ·(unknown), Truc T. Tran, Tariq Nisar, Diana Panesso, Kavindra V. Singh, (unknown), (unknown), (unknown), (unknown), An Q Dinh, German Contreras, Blake Hanson, Marcus Zervos, Lilian M. Abbo, Luis Shimose, Samuel A. Shelburne, César A. Arias, William R. Miller	0
3	Impact of pre‐transplant carbapenem‐resistant Enterobacterales colonization and/or infection on solid organ transplant outcomes 2021 ·Clinical Transplantation ·Sarah Taimur, Stephanie M. Pouch, Nicole Zubizarreta, Madhu Mazumdar, Meenakshi Rana, Gopi Patel, (unknown), Rebecca Pellett Madan, E.J. Kwak, Emily A. Blumberg, Michael J. Satlin, (unknown), Wanessa Trindade Clemente, Marcus Zervos, Ricardo M. La Hoz, Shirish Huprikar	23
4	Evaluation of COVID-19 Vaccine Attitudes among Arab American Healthcare Professionals Living in the United States 2021 ·Vaccines ·Anita Shallal, Evi Abada, (unknown), (unknown), Linda Kaljee, (unknown), (unknown), (unknown), (unknown), Seongho Kim, Michele L. Coté, Vijaya Arun Kumar, Marcus Zervos, Rouba Ali‐Fehmi	7
5	Antimicrobial stewardship programs in adult intensive care units in Latin America: Implementation, assessments, and impact on outcomes 2021 ·Infection Control and Hospital Epidemiology ·Rodolfo Quirós, Ana C. Bardossy, (unknown), Jeannete Zurita, (unknown), Marcelo Carneiro, S Del Guerra, Julio C. Medina, (unknown), (unknown), Silvio Vega, (unknown), José M. Munita, (unknown), Gina Maki, (unknown), Marcus Zervos, (unknown)	18
6	Association Between Implementation of a Universal Face Mask Policy for Healthcare Workers in a Health Care System and SARS-CoV-2 Positivity Testing Rate in Healthcare Workers 2021 ·Journal of Occupational and Environmental Medicine ·Dee Dee Wang, William W. O’Neill, Marcus Zervos, John E. McKinnon, David Allard, George Alangaden, Lonni Schultz, Laila Poisson, (unknown), Steven N. Kalkanis, Geehan Suleyman	8
7	Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis 2020 ·Journal of Clinical Investigation ·Vance G. Fowler, Anita Das, (unknown), Raymond Schuch, Roger J. Pomerantz, Luis Jáuregui-Peredo, Adam Bressler, David C. Evans, Gregory J. Moran, Mark E. Rupp, Robert A. Wise, G. Ralph Corey, Marcus Zervos, Pamela S. Douglas, Cara Cassino	95
8	Feasibility Study of the World Health Organization Health Care Facility-Based Antimicrobial Stewardship Toolkit for Low- and Middle-Income Countries 2020 ·Antibiotics ·Gina Maki, Ingrid Smith, Sarah Paulin, Linda Kaljee, Watipaso Kasambara, (unknown), Pem Chuki, Priscilla Rupali, (unknown), Deepak Bajracharya, Lisa Barrow, (unknown), (unknown), Marcus Zervos	20
9	Trends in Legionnaires’ Disease-Associated Hospitalizations, United States, 2006–2010 2020 ·Open Forum Infectious Diseases ·(unknown), Paul E. Kilgore, Abdulbaset Salim, Shawn P. McElmurry, Marcus Zervos	6
10	Cardiac Complications Attributed to Hydroxychloroquine: A Systematic Review of the Literature Pre-COVID-19 2020 ·Current Cardiology Reviews ·(unknown), Dee Dee Wang, Kelly Malette, (unknown), Guson Kang, Chak-Yu So, Mir B. Basir, (unknown), John E. McKinnon, Marcus Zervos, William W. O’Neill	10
11	Multidrug-resistant Organisms in Hospitals: What Is on Patient Hands and in Their Rooms? 2019 ·Clinical Infectious Diseases ·Lona Mody, Laraine Washer, Keith S. Kaye, Kristen Gibson, Sanjay Saint, Luis Felipe Reyes, Marco Cassone, Julia Mantey, Jie Cao, (unknown), Mary Beth Perri, Hugo Sax, Vineet Chopra, Marcus Zervos	47
12	Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments 2019 ·Open Forum Infectious Diseases ·Erin K McCreary, Ravina Kullar, Matthew Geriak, Evan J Zasowski, (unknown), Lucas Schulz, (unknown), (unknown), Fadi Haddad, Michael J. Rybak, Marcus Zervos, George Sakoulas, Warren E. Rose	65
13	Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia 2019 ·Antimicrobial Agents and Chemotherapy ·Matthew Geriak, Fadi Haddad, (unknown), Warren E. Rose, Ravina Kullar, Kerry L. LaPlante, (unknown), (unknown), (unknown), Marcus Zervos, Victor Nizet, George Sakoulas	138
14	Interplay Between Patient Colonization and Environmental Contamination With Vancomycin-Resistant Enterococci and Their Association With Patient Health Outcomes in Postacute Care 2019 ·Open Forum Infectious Diseases ·Marco Cassone, Ziwei Zhu, Julia Mantey, Kristen Gibson, Mary Beth Perri, Marcus Zervos, Evan S. Snitkin, Betsy Foxman, Lona Mody	11
15	Impact of an antimicrobial stewardship intervention in India: Evaluation of post-prescription review and feedback as a method of promoting optimal antimicrobial use in the intensive care units of a tertiary-care hospital 2019 ·Infection Control and Hospital Epidemiology ·Priscilla Rupali, (unknown), (unknown), John Victor Peter, Subramani Kandasamy, (unknown), (unknown), (unknown), Rajiv Karthik, O C Abraham, Joy Sarojini Michael, Hema Paul, Balaji Veeraraghavan, Binila Chacko, Visalakshi Jeyaseelan, George Alangaden, (unknown), Marcus Zervos	27
16	Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study 2017 ·International Journal of Infectious Diseases ·Samia Arshad, Vanthida Huang, Pamela Hartman, Mary Beth Perri, Daniela Sales Alviano, Marcus Zervos	43
17	Safety and efficacy of commonly used antimicrobial agents in the treatment of enterococcal infections: a review 2015 ·Expert Opinion on Drug Safety ·Geehan Suleyman, Marcus Zervos	11
18	DNA Analysis in the Study of the Epidemiology of Nosocomial Candidiasis 2009 ·Infection Control and Hospital Epidemiology ·Louise M. Dembry, (unknown), Marcus Zervos	4
19	Treatment Options for Uncomplicated Community-Acquired Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus : Oral Antimicrobial Agents 2008 ·Surgical Infections ·Marcus Zervos	10
20	Enterococcal Infections: An Increasing Problem in Hospitalized Patients 1988 ·Infection Control and Hospital Epidemiology ·Margaret S. Terpenning, Marcus Zervos, Dennis R. Schaberg, Carol A. Kauffman	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact